$4.57
3.16% today
Nasdaq, Apr 02, 10:00 pm CET
ISIN
US38246G1085
Symbol
GDRX

GoodRx Holdings Stock price

$4.43
-0.42 8.66% 1M
-2.50 36.08% 6M
-0.22 4.73% YTD
-2.67 37.61% 1Y
-15.25 77.49% 3Y
-28.57 86.58% 5Y
-28.57 86.58% 10Y
Nasdaq, Closing price Tue, Apr 01 2025
+0.02 0.45%
ISIN
US38246G1085
Symbol
GDRX

Key metrics

Market capitalization $1.70b
Enterprise Value $1.79b
P/E (TTM) P/E ratio 103.99
EV/FCF (TTM) EV/FCF 9.82
EV/Sales (TTM) EV/Sales 2.26
P/S ratio (TTM) P/S ratio 2.14
P/B ratio (TTM) P/B ratio 2.34
Revenue growth (TTM) Revenue growth 5.61%
Revenue (TTM) Revenue $792.32m
EBIT (operating result TTM) EBIT $88.31m
Free Cash Flow (TTM) Free Cash Flow $182.65m
Cash position $448.35m
EPS (TTM) EPS $0.04
P/E forward 26.83
P/S forward 2.06
EV/Sales forward 2.18
Short interest 5.99%
Show more

Is GoodRx Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

GoodRx Holdings Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a GoodRx Holdings forecast:

9x Buy
50%
8x Hold
44%
1x Sell
6%

Analyst Opinions

18 Analysts have issued a GoodRx Holdings forecast:

Buy
50%
Hold
44%
Sell
6%

Financial data from GoodRx Holdings

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
792 792
6% 6%
100%
- Direct Costs 118 118
23% 23%
15%
675 675
13% 13%
85%
- Selling and Administrative Expenses 394 394
10% 10%
50%
- Research and Development Expense 123 123
3% 3%
15%
158 158
39% 39%
20%
- Depreciation and Amortization 70 70
25% 25%
9%
EBIT (Operating Income) EBIT 88 88
330% 330%
11%
Net Profit 16 16
285% 285%
2%

In millions USD.

Don't miss a Thing! We will send you all news about GoodRx Holdings directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GoodRx Holdings Stock News

Positive
Seeking Alpha
9 days ago
GoodRx is a great small-cap value stock to buy amid the recent downturn. I'm upgrading the stock to a buy. GoodRx showcases strong adjusted EBITDA despite slower growth, making it an attractive target for private equity deals as public equities become less appealing. The company's new CEO is driving a wholesale change in business strategy, chasing relationships directly with pharmaceutical manu...
Neutral
Business Wire
16 days ago
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement, effective immediately. Aaron will be responsible for the management and financial performance of GoodRx's Rx Mar...
Neutral
Business Wire
23 days ago
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today released a new report, The Prescription Drug Gender Divide, detailing how women shoulder a significantly greater out-of-pocket cost burden than men. The data shows that in 2024, women spent $8.8 billion – or 30% – more than men on out-of-pocket prescription costs. Combine...
More GoodRx Holdings News

Company Profile

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The firm offers information and tools to help consumers compare prices for prescription drugs. It operates applications and websites that provide prices and discounts at local and mail-order pharmacies. The company was founded in September 2015 and is headquartered in Santa Monica, CA.

Head office United States
CEO Wendy Barnes
Employees 738
Founded 2015
Website www.goodrx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today